Cancer research

SRI’s cancer research laboratory founded in 1956

In 1956, SRI began a still-continuing series of research projects in synthesis of possible anticancer agents for the National Institutes of Health (NIH).

The first of many NIH contracts lasted for 25 years, and SRI published more than 100 articles in the field of cancer chemotherapy in refereed journals. These papers, plus innumerable presentations at symposia, put SRI on the map in the field of cancer research.

In 2011, the National Cancer Institute awarded SRI two five-year contracts to examine the safety and efficacy of several potential treatments for cancer and other diseases of critical importance to the nation’s health.

Read our 75th anniversary blog feature

75 years of innovation: Cancer research

Read more from SRI

  • surgeons around a surgical robot

    The SRI research behind today’s surgical robotics

    Intuitive’s da Vinci 5 system represents a major leap in robotic-assisted medicine. It all started at SRI, which continues to advance teleoperation technologies.

  • a collage of digital graphs

    A banner year for quantum

    SRI-managed QED-C’s annual report on quantum trends captures an industry accelerating rapidly from technical promise toward major global impact.

  • ICE Cube containing SRI’s aerogel experiment, photographed prior to launch. Source: Aerospace Applications North America

    An SRI carbon capture experiment launches into space

    By synthesizing carbon-absorbing aerogels in microgravity, SRI research will give us a rare glimpse into how these materials could be radically improved.